News Conference News ESC 2018 Myocardial Injury or MI? New Universal Definition Aims for Clarity Todd Neale September 05, 2018
News Conference News ESC 2018 High-STEACS: Sensitive Troponin Tests Rule Out MI, but Have No Impact on Hard Events Shelley Wood August 29, 2018
News Daily News High-Sensitivity Troponin T Safely Rules Out More MI Patients, and Faster, Than Conventional Assay Michael O'Riordan August 14, 2018
News Daily News ESC Algorithm Safely Rules Out NSTEMI, but Caution May Be Warranted in the US Todd Neale August 01, 2018
News Conference News SCCT 2018 How Will High-Sensitivity Troponin Tests Affect CTA Use in the ED? Yael L. Maxwell July 24, 2018
News Daily News Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease Michael O'Riordan June 07, 2018
News Daily News Advent of High-Sensitivity Troponin Tests in Sweden Leads to Only Small Uptick in MI Diagnoses Caitlin E. Cox June 06, 2018
News Daily News High-Sensitivity Troponins May Help Identify Obstructive CAD in Stable, Symptomatic Patients Yael L. Maxwell March 30, 2018
News Daily News Risk Scores Combined With Lower Troponin Cut Points May Help Refine Rule-Out Tests for Chest Pain Shelley Wood February 05, 2018
News Daily News High-Sensitivity Troponin May Help Uncover Heart Failure Risk Todd Neale January 11, 2018
News Daily News High-Sensitivity Troponin T Assay Picks Out Low-Risk Patients in US Emergency Departments Todd Neale December 14, 2017
News Conference News AHA 2017 Low High-Sensitivity Troponin I Cutoff May Allow Discharge From ED for Many Todd Neale November 11, 2017
News Daily News Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk Todd Neale October 23, 2017
News Daily News High-Sensitivity Troponin Tests Still Useful in Patients With Renal Dysfunction and Suspected ACS, With Caveats Yael L. Maxwell October 06, 2017
News Conference News ESC 2017 ESC Algorithm for Rapidly Diagnosing NSTEMI Works, Study Confirms Todd Neale September 08, 2017
News Daily News Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests Michael O'Riordan August 14, 2017
News Daily News CV Risk Higher With Modestly Elevated Troponin Levels, but Clinical Relevance Remains Unclear Todd Neale July 24, 2017
News Daily News Rapid Rule-Out Strategy With High-Sensitivity Troponin Shows Promise Ahead of US Commercial Availability of Test L.A. McKeown April 17, 2017
News Daily News ICTUS: No Benefit at 10 Years With Early Invasive Strategy in NSTE ACS Patients Michael O'Riordan April 11, 2017